NCAC (Newcourt Acquisition Corp) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

NCAC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NCAC and 80,000+ other tickers.
See exactly how NCAC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NCAC and 80,000+ other tickers.
Newcourt Acquisition Corp currently lacks substantial business activities. Its core mission is to complete a strategic transaction, such as a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or a similar corporate combination, with one or more target enterprises. This entity was established in 2021 and operates from Oakland, California.

Newcourt Acquisition (NASDAQ: NCAC ) stock is falling on Tuesday as the special purpose acquisition company (SPAC) provides investors with an update on its business combination plans. According to a press release, the business combination conditions between it and Pubco haven't been satisfied yet.

NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (“Newcourt”) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the “Business Combination”) pursuant to the Amended and Restated Business Combination Agreement, dated July 31, 2023 (as amended, supplemented, or otherwise modified from time to time, the “Amended and Restated Business Combination Agreement”), by and among Newcourt, Newcourt SPAC Sponsor LLC, Psyence Group Inc. (CSE: PSYG) (“Psyence”), Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada (“Pubco”), Psyence (Cayman) Merger Sub, Psyence Biomed Corp., and Psyence Biomed II Corp. have not yet been satisfied and the business combination has not closed. The parties are working together to expeditiously satisfy such closing conditions, including obtaining the approval of Nasdaq to list Pubco's ordinary shares following the closing of the business combination. On January 22, 2024, Newcourt's shareholders approved to extend the date by which Newcourt must consummate its initial business combination from January 22, 2024 to February 22, 2024. There can be no assurance that the business combination will be consummated by February 22, 2024.

Otunba Olusegun Runsewe, Director-General National Council for Arts and Culture (NCAC), says President Bola Tinubu has the capacity to take the nation’s tourism sector to [...] The post Tinubu has capacity to transform tourism sector – Runsewe appeared first on Warri Tatafo...